Jul 27 2024
Here is a richly illustrated open-access editorial of the development and physiologic function of efanesoctocog alfa (Altuviiio®, Sanofi), which features a half-life 4X that of current concentrates: Chowdary P. Bioengineered factor VIII–more innovation for Hemophilia A. N Engl J Med. 2024;391:277–82. doi: 10.1056/NEJMe2313795. PMID: 39018538.
Comments (0)
Bleeding Disorders
No comments here.